Profound Medical Analyst Ratings
Profound Medical Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/04/2023 | — | Raymond James | Downgrades | Strong Buy → Outperform | |
| 05/11/2023 | 77.87% | TD Cowen | $14 → $18 | Maintains | Outperform |
| 05/11/2023 | 55.63% | Alliance Global Partners | $13.15 → $15.75 | Maintains | Buy |
| 03/21/2023 | -1.19% | Jefferies | $5.5 → $10 | Downgrades | Buy → Equal-Weight |
| 11/04/2022 | — | Raymond James | Upgrades | Outperform → Strong Buy | |
| 03/07/2022 | 38.34% | Cowen & Co. | $28 → $14 | Maintains | Outperform |
| 02/22/2022 | 127.27% | Raymond James | $28 → $23 | Downgrades | Strong Buy → Outperform |
| 09/15/2020 | — | Jefferies | Initiates Coverage On | → Buy | |
| 09/10/2020 | 117.39% | Lake Street | → $22 | Initiates Coverage On | → Buy |
| 04/01/2020 | 48.22% | Cowen & Co. | → $15 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 08/04/2023 | - | 雷蒙德·詹姆斯 | 评级下调 | 强势买入→跑赢大盘 | |
| 2023年05月11日 | 77.87% | TD Cowen | $14→$18 | 维护 | 跑赢大盘 |
| 2023年05月11日 | 55.63% | 联盟全球合作伙伴 | $13.15→$15.75 | 维护 | 买 |
| 03/21/2023 | -1.19% | 杰富瑞 | $5.5→$10 | 评级下调 | 购买→等重产品 |
| 11/04/2022 | - | 雷蒙德·詹姆斯 | 升级 | 跑赢→强势买入 | |
| 03/07/2022 | 38.34% | 考恩公司 | $28→$14 | 维护 | 跑赢大盘 |
| 02/22/2022 | 127.27% | 雷蒙德·詹姆斯 | $28→$23 | 评级下调 | 强势买入→跑赢大盘 |
| 2020/09/15 | - | 杰富瑞 | 开始承保 | →购买 | |
| 09/10/2020 | 117.39% | 莱克街 | →$22 | 开始承保 | →购买 |
| 04/01/2020 | 48.22% | 考恩公司 | →$15 | 开始承保 | →跑赢大盘 |
What is the target price for Profound Medical (PROF)?
深奥医疗(教授)的目标价是多少？
The latest price target for Profound Medical (NASDAQ: PROF) was reported by Raymond James on August 4, 2023. The analyst firm set a price target for $0.00 expecting PROF to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
深奥医疗(纳斯达克：PRO)的最新目标价是由Raymond James于2023年8月4日报道的。这家分析公司将目标价定为0.00美元，预计Prof将在12个月内下跌(跌幅可能为-100.00%)。去年有5家分析公司公布了评级。
What is the most recent analyst rating for Profound Medical (PROF)?
深奥医疗(教授)的最新分析师评级是多少？
The latest analyst rating for Profound Medical (NASDAQ: PROF) was provided by Raymond James, and Profound Medical downgraded their outperform rating.
深奥医疗(纳斯达克：PROF)的最新分析师评级由Raymond James提供，深奥医疗下调了其表现优于大盘的评级。
When is the next analyst rating going to be posted or updated for Profound Medical (PROF)?
深奥医疗(教授)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Profound Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Profound Medical was filed on August 4, 2023 so you should expect the next rating to be made available sometime around August 4, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与深奥医疗的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。深奥医疗的上一次评级是在2023年8月4日提交的，所以你应该预计下一次评级将在2024年8月4日左右的某个时候提供。
Is the Analyst Rating Profound Medical (PROF) correct?
分析师对深奥医疗(教授)的评级正确吗？
While ratings are subjective and will change, the latest Profound Medical (PROF) rating was a downgraded with a price target of $0.00 to $0.00. The current price Profound Medical (PROF) is trading at is $10.12, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的深层医疗(教授)评级为下调，目标价为0.00美元至0.00美元。深奥医疗(教授)目前的交易价格为10.12美元，超出了分析师的预测范围。